Skip to main content

Vaccinia FDA Approval History

FDA Approved: Yes (First approved May 2, 2005)
Brand name: Vaccinia
Generic name: vaccinia immune globulin intravenous (human)
Dosage form: Injection
Company: DynPort Vaccine Company LLC
Treatment for: Smallpox Vaccine Reaction

Vaccinia Immune Globulin Intravenous (Human) (VIGIV) indicated for the treatment of complications from smallpox vaccination

Development timeline for Vaccinia

Feb 18, 2005Approval Vaccinia DynPort Vaccine Company LLC - Treatment for Complications of Smallpox Vaccination
Aug  3, 2004DVC Announces FDA Acceptance for Filing of Vaccinia Immune Globulin BLA

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.